MyFinsight
Home
Blog
About
Contact
Download
Download image
Interest income
$32K
Net loss and other
comprehensive loss
-$3,177K
Total other income,
net
$32K
Loss from operations
-$3,209K
(-120.25%↓ Y/Y)
Total cost and
expenses
$3,209K
(108.65%↑ Y/Y)
General and
administrative
$2,479K
(65.05%↑ Y/Y)
Research and development
$730K
(1927.78%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Cyclerion Therapeutics, Inc. (CYCN)
Cyclerion Therapeutics, Inc. (CYCN)